SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-23-000093
Filing Date
2023-09-26
Accepted
2023-09-26 16:34:15
Documents
15
Period of Report
2023-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20230926.htm   iXBRL 8-K 25256
2 EX-99.1 lumo-20230926x8kxex991.htm EX-99.1 31238
7 image_0a.jpg GRAPHIC 2692
  Complete submission text file 0001126234-23-000093.txt   226869

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20230926.xsd EX-101.SCH 2252
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20230926_def.xml EX-101.DEF 14926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20230926_lab.xml EX-101.LAB 29066
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20230926_pre.xml EX-101.PRE 15561
9 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20230926_htm.xml XML 2786
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 231280850
SIC: 2834 Pharmaceutical Preparations